| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 04/04/2014 | 11:00 | Marketwired | Masimo Expands Its Board of Directors With Appointment of Medical Device Executive Craig Reynolds | NASDAQ:RESP | Respironics (MM) |
| 14/03/2008 | 17:03 | Edgar (US Regulatory) | Respironics Inc - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:RESP | Respironics (MM) |
| 12/03/2008 | 16:47 | Edgar (US Regulatory) | Respironics Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:RESP | Respironics (MM) |
| 10/03/2008 | 22:37 | Edgar (US Regulatory) | Respironics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RESP | Respironics (MM) |
| 07/03/2008 | 19:54 | Edgar (US Regulatory) | Respironics Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:RESP | Respironics (MM) |
| 07/03/2008 | 00:05 | PR Newswire (US) | QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Inde | NASDAQ:RESP | Respironics (MM) |
| 12/02/2008 | 22:56 | Edgar (US Regulatory) | Respironics Inc - Amended Statement of Ownership (SC 13G/A) | NASDAQ:RESP | Respironics (MM) |
| 11/02/2008 | 21:20 | Edgar (US Regulatory) | Respironics Inc - Statement of Ownership (SC 13G) | NASDAQ:RESP | Respironics (MM) |
| 11/02/2008 | 17:16 | Edgar (US Regulatory) | Respironics Inc - Quarterly Report (10-Q) | NASDAQ:RESP | Respironics (MM) |
| 24/01/2008 | 13:30 | PR Newswire (US) | Respironics Reports Record Financial Results for Fiscal Year 2008 Second Quarter, Comments on Previously Announced Merger Agreem | NASDAQ:RESP | Respironics (MM) |
| 03/01/2008 | 23:19 | Edgar (US Regulatory) | Respironics Inc - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:RESP | Respironics (MM) |
| 03/01/2008 | 22:53 | Edgar (US Regulatory) | Respironics Inc - Tender offer statement by Third Party (SC TO-T) | NASDAQ:RESP | Respironics (MM) |
| 27/12/2007 | 12:00 | Edgar (US Regulatory) | Respironics Inc - Current report filing (8-K) | NASDAQ:RESP | Respironics (MM) |
| 26/12/2007 | 18:36 | Edgar (US Regulatory) | Respironics Inc - Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:RESP | Respironics (MM) |
| 26/12/2007 | 18:28 | PR Newswire (US) | Featured Stocks on Today's Edition of the Analyst's Review: RESP, RMD, IVC, SYK | NASDAQ:RESP | Respironics (MM) |
| 21/12/2007 | 08:15 | PR Newswire (US) | Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share | NASDAQ:RESP | Respironics (MM) |
| 25/10/2007 | 13:00 | PR Newswire (US) | Respironics Reports Record Financial Results for Fiscal Year 2008 First Quarter, Achieves 20 Percent Global Sleep Therapy Revenu | NASDAQ:RESP | Respironics (MM) |
| 17/10/2007 | 15:00 | PR Newswire (US) | Respironics to Webcast Fiscal 2008 First Quarter Conference Call | NASDAQ:RESP | Respironics (MM) |
| 08/10/2007 | 17:14 | PR Newswire (US) | Dixtal Medical Purchases Novametrix Pulse Oximetry Business from Respironics | NASDAQ:RESP | Respironics (MM) |
| 02/10/2007 | 13:59 | PR Newswire (US) | Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market | NASDAQ:RESP | Respironics (MM) |
| 25/07/2007 | 22:00 | PR Newswire (US) | Respironics Reports Record Financial Results for Fiscal Year 2007 Fourth Quarter and Full Year, Achieves 21 Percent Global Sleep | NASDAQ:RESP | Respironics (MM) |
| 12/07/2007 | 15:00 | PR Newswire (US) | Respironics to Webcast Fiscal 2007 Fourth Quarter and Year End Conference Call | NASDAQ:RESP | Respironics (MM) |
| 26/04/2007 | 13:59 | PR Newswire (US) | Respironics Reports Record Financial Results for Fiscal Year 2007 Third Quarter, Achieves 21 Percent Global Sleep Therapy Revenu | NASDAQ:RESP | Respironics (MM) |
| 24/04/2007 | 14:00 | PR Newswire (US) | Respironics Showcases Latest Technologies at Medtrade Spring; Building Upon Strong Fiscal Third Quarter Performance, Announces A | NASDAQ:RESP | Respironics (MM) |
| 12/04/2007 | 16:00 | PR Newswire (US) | Respironics to Webcast Fiscal 2007 Third Quarter Conference Call | NASDAQ:RESP | Respironics (MM) |
| 16/03/2007 | 15:30 | PR Newswire (US) | Respironics' I-neb(R) Device Utilized in Clinical Evaluation Of Interferon Gamma in Idiopathic Pulmonary Fibrosis Patients | NASDAQ:RESP | Respironics (MM) |
| 07/03/2007 | 14:30 | PR Newswire (US) | Respironics Receives 510(k) Clearance from FDA for BiPAP(R) autoSV(TM) Device Designed for Complicated Sleep-Disordered Breathin | NASDAQ:RESP | Respironics (MM) |
| 29/01/2007 | 16:00 | PR Newswire (US) | Respironics to Webcast Analyst Day Presentations on Thursday, February 1, 2007 | NASDAQ:RESP | Respironics (MM) |
| 25/01/2007 | 12:58 | PR Newswire (US) | Respironics Reports Record Financial Results for Fiscal Year 2007 Second Quarter, M-series CPAP Fully Launched, OptiLife(TM) Pat | NASDAQ:RESP | Respironics (MM) |
| 12/01/2007 | 14:00 | PR Newswire (US) | Respironics to Webcast Fiscal 2007 Second Quarter Conference Call | NASDAQ:RESP | Respironics (MM) |